S Kant’s dispersible isoniazid tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
News
22nd Invitation to Manufacturers of Antituberculosis Medicines to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
M
The Invitation to Manufacturers of Antituberculosis Medicines to su
First azithromycin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First NRT products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
ViiV Healthcare’s abacavir/dolutegravir/lamivudine pediatric dispersible tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First cefiderocol prequalified
M
WHO Prequalification Unit (PQT) added the below new p
Merck’s praziquantel prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First miltefosine prequalified
M
WHO Prequalification Unit (PQT) added the below new p
Renata’s ethinylestradiol/levonorgestrel tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new p
First primaquine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zydus’ daclatasvir products prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Svizera’s isoniazid 300 mg tabl prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Aurobindo’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Zhejiang Huahai’s nirmatrelvir + ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shouguang Fukang’s sulfamethoxazole/trimetoprim tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Cipla’s molnupiravir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
S Kant’s pyridoxine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
First products for Ebola Virus Disease prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First bedaquiline product prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
- TB396 - Bedaquiline fumarate - 100mg - Tablet - Lupin Ltd - INDIA
First paediatric abacavir/dolutegravir/lamivudine 60mg/5mg/30mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
Zhejiang Apeloa Kangyu’s nirmatrelvir + ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Vaccines prequalification prioritity list 2024-2026
V
For more information click here
10th Invitation to manufacturers of reproductive health products to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines
M
Addition:
Under section: 9. Antifibrinolytics
22nd Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
M
New Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
Addition:
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-449) manufactured by Shanghai Desano Chemical Pharmac
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Molnupiravir (WHOAPI-438) manufactured by Optimus Drugs Pvt Ltd, has been